Target Name: ZNF506
NCBI ID: G440515
Review Report on ZNF506 Target / Biomarker Content of Review Report on ZNF506 Target / Biomarker
ZNF506
Other Name(s): Zinc finger protein 506 (isoform 1) | ZN506_HUMAN | zinc finger protein 506 | Zinc finger protein 506 | Zinc finger protein 506, transcript variant 1 | ZNF506 variant 1

ZNF506: A Potential Drug Target and Biomarker for Zinc Finger Proteins

Zinc finger proteins (ZFPs) are a family of non-coding RNAs that play a crucial role in various cellular processes. ZFPs are characterized by the presence of a Z-shaped nucleotide base in their sequence, which is derived from the base pairs of DNA. ZFPs have been implicated in a wide range of physiological processes, including cell growth, differentiation, and disease. One of the most well-studied ZFPs is ZNF506, which is a 21-kDa protein that is expressed in various tissues and cells. In this article, we will discuss the potential drug target and biomarker properties of ZNF506.

Potential Drug Target

ZNF506 is a potential drug target due to its unique structure and biology. The ZNF506 protein is a nuclear protein that is composed of a unique nucleotide-binding oligomeric domain (NBD) and a transmembrane region (TMD). The NBD is responsible for the protein's nuclear localization, while the TMD is responsible for the protein's membrane localization. This unique structure allows ZNF506 to interact with various nuclear and membrane-resident small molecules, making it an attractive target for drug development.

Several studies have suggested that ZNF506 is involved in various cellular processes, including cell growth, apoptosis, and inflammation. ZNF506 has been shown to play a positive role in cell proliferation and has been associated with the growth of various types of cancer cells. Additionally, ZNF506 has been shown to be involved in cell apoptosis, which is a critical mechanism that helps maintain tissue homeostasis.

Furthermore, ZNF506 has been implicated in the regulation of various cellular signaling pathways, including the TGF-β pathway. TGF-β is a well-known signaling pathway that is involved in cell growth, differentiation, and inflammation. ZNF506 has been shown to play a role in the regulation of TGF-β signaling by interacting with the transcription factor Smad2.

Potential Biomarker

ZNF506 has also been suggested as a potential biomarker for various diseases. For example, ZNF506 has been shown to be involved in the regulation of angiogenesis, which is the process by which new blood vessels are formed. ZNF506 has been shown to play a positive role in the regulation of angiogenesis by interacting with the transcription factor FGF1.

Additionally, ZNF506 has been shown to be involved in the regulation of stem cell proliferation and maintenance. stem cells are a diverse cell type that have the potential to differentiate into various cell types in the body. ZNF506 has been shown to play a positive role in the regulation of stem cell proliferation by interacting with the transcription factor Sox2.

Conclusion

In conclusion, ZNF506 is a unique protein that has the potential to be a drug target and biomarker. Its unique structure and biology make it an attractive target for drug development, and its involvement in various cellular processes and signaling pathways make it a promising biomarker for disease. Further research is needed to fully understand the role of ZNF506 in cellular and biological processes, as well as its potential as a drug and biomarker.

Protein Name: Zinc Finger Protein 506

Functions: May be involved in transcriptional regulation

The "ZNF506 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF506 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF507 | ZNF510 | ZNF511 | ZNF512 | ZNF512B | ZNF513 | ZNF514 | ZNF516 | ZNF516-DT | ZNF517 | ZNF518A | ZNF518B | ZNF519 | ZNF519P3 | ZNF521 | ZNF524 | ZNF525 | ZNF526 | ZNF527 | ZNF528 | ZNF528-AS1 | ZNF529 | ZNF529-AS1 | ZNF530 | ZNF532 | ZNF534 | ZNF536 | ZNF540 | ZNF541 | ZNF542P | ZNF543 | ZNF544 | ZNF546 | ZNF547 | ZNF548 | ZNF549 | ZNF550 | ZNF551 | ZNF552 | ZNF554 | ZNF555 | ZNF556 | ZNF557 | ZNF558 | ZNF559 | ZNF559-ZNF177 | ZNF560 | ZNF561 | ZNF561-AS1 | ZNF562 | ZNF563 | ZNF564 | ZNF565 | ZNF566 | ZNF566-AS1 | ZNF567 | ZNF568 | ZNF569 | ZNF56P | ZNF57 | ZNF570 | ZNF571 | ZNF571-AS1 | ZNF572 | ZNF573 | ZNF574 | ZNF575 | ZNF576 | ZNF577 | ZNF578 | ZNF579 | ZNF580 | ZNF582 | ZNF582-DT | ZNF583 | ZNF584 | ZNF585A | ZNF585B | ZNF586 | ZNF587 | ZNF587B | ZNF589 | ZNF592 | ZNF593 | ZNF594 | ZNF594-DT | ZNF595 | ZNF596 | ZNF597 | ZNF598 | ZNF599 | ZNF600 | ZNF603P | ZNF605 | ZNF606 | ZNF607 | ZNF608 | ZNF609 | ZNF610 | ZNF611